ARCT Competitors & Alternatives
Compare Arcturus Therapeutics Holdings Inc with similar stocks in the same industry
Biotechnology
ARCT
Main Stock$9.97
Tradestie Score
64
Market Cap
$556.12M
Revenue Growth
-0.9%
Analyst Upside
+138.7%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.39
|
$350.98M | - | 68 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.70
|
$332.96M | - | 44 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.60
|
$328.62M | - | 49 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$6.81
|
$307.12M | - | 63 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.00
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.58
|
$297.23M | - | 41 | Compare |
|
OMER
Omeros Corporation
|
$16.58
|
$281.75M | 13.6 | 66 | Compare |
|
DBVT
DBV Technologies S.A.
|
$9.73
|
$275.54M | - | 63 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.14
|
$269.08M | 0.1 | 50 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$10.95
|
$265.45M | 21.0 | 46 | Compare |
More ARCT Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry